BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//pretalx//sciencenext.org//ifos2026//XXHBDV
BEGIN:VTIMEZONE
TZID:EET
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20061029T000000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20071028T050000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20141026T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20151108T050000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=11;UNTIL=20151108T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20160907T010000
RRULE:FREQ=YEARLY;BYDAY=1WE;BYMONTH=9
TZNAME:+03
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20060326T000000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20070325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20100328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20110328T040000
RRULE:FREQ=YEARLY;BYDAY=4MO;BYMONTH=3;UNTIL=20110328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20120325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20130331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20140331T040000
RRULE:FREQ=YEARLY;BYDAY=5MO;BYMONTH=3;UNTIL=20140331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20150329T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20160327T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:pretalx-ifos2026-EHGNCQ@sciencenext.org
DTSTART;TZID=EET:20260910T073000
DTEND;TZID=EET:20260910T084500
DESCRIPTION:<p style="margin-left: 0px!important\;">Panel presentation of C
 urrent Approach to Auditory Neuropathy Spectrum Disease</p><p style="margi
 n-left: 0px!important\;"><strong>Background</strong>: Approximately 10% of
  children born with a permanent hearing loss have auditory neuropathy. Imp
 lementation of universal newborn hearing screening has led to early detect
 ion and intervention. An increased understanding of the long-term achievem
 ents of children with auditory neuropathy is essential to developing a com
 prehensive account of expected outcomes of children for improving counsell
 ing and clinical management.</p><p style="margin-left: 0px!important\;"><s
 trong>Objective</strong>. This study examined language and speech outcomes
  in a population-based cohort of 9-year-old children with hearing loss and
  auditory neuropathy\, and investigated factors influencing outcomes.</p><
 p style="margin-left: 0px!important\;"><strong>Method.</strong> Receptive 
 and expressive language skills\, speech output accuracy\, and a diverse se
 t of cognitive\, demographic and audiological\, variables (including age a
 t device fitting) were evaluated at 3-\, 5- and 9-years of age using direc
 t assessment and caregiver report. Multiple regression analyses were used 
 to address two questions: 1) Do language and speech outcomes at earlier ag
 es predict language and speech outcomes at 9 years of age? 2) Which cognit
 ive\, demographic and audiological variables measured at 9 years of age pr
 edict concurrent language and speech outcomes after controlling for early 
 language and speech outcomes?</p><p style="margin-left: 0px!important\;"><
 strong>Result</strong> <strong>and Discussion</strong>. The influence of c
 ognitive\, demographic and audiological variables\, including auditory neu
 ropathy\, on 9-year outcomes was quantified. The implications of results o
 n clinical best-practice management of children with hearing loss and audi
 tory neuropathy will be discussed.</p>
DTSTAMP:20260618T223237Z
LOCATION:Hearing Implant 3
SUMMARY:Longitudinal speech and language outcomes of children with auditory
  neuropathy - George Tavartkiladze\, Ayça Çiprut\, Homood almutairi\, Wa
 faa El Kholy\, Teresa Ching\, Mehmet YARALI
URL:https://sciencenext.org/ifos2026/talk/EHGNCQ/
END:VEVENT
END:VCALENDAR
